@PharmaGuy and @SpitzStrategy square off on the issue of whether or not Pharma should create eBooks for patient education.
Pharma Guy takes the side of #PHARMAFAIL by citing two examples, stating that pharma either repurposes content quickly and cheaply, but with limited patient engagement, or creates sophisticated interactive pieces that work well but are too costly and complicated.
Spitz takes the side of #PHARMAFORWARD citing the same examples, instead imploring that pharma needs to experiment and learn about emerging tech before diving in. What do you think?